LY6E impairs coronavirus fusion and confers immune control of viral disease S Pfaender, KB Mar, E Michailidis, A Kratzel, IN Boys, P V’kovski, W Fan, ... Nature microbiology 5 (11), 1330-1339, 2020 | 198 | 2020 |
A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication RB Richardson, MB Ohlson, JL Eitson, A Kumar, MB McDougal, IN Boys, ... Nature microbiology 3 (11), 1214-1223, 2018 | 152* | 2018 |
LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step KB Mar, NR Rinkenberger, IN Boys, JL Eitson, MB McDougal, ... Nature communications 9 (1), 3603, 2018 | 108 | 2018 |
RTP4 is a potent IFN-inducible anti-flavivirus effector engaged in a host-virus arms race in bats and other mammals IN Boys, E Xu, KB Mar, C Pamela, JL Eitson, B Moon, JW Schoggins Cell host & microbe 28 (5), 712-723. e9, 2020 | 38 | 2020 |
Identification of atovaquone, ouabain and mebendazole as FDA approved drugs Tar-geting SARS-CoV-2 (version 4) A Farag, P Wang, IN Boys, JL Eitson, MB Ohlson, W Fan, MB McDougal, ... | 34* | 2020 |
Shiftless inhibits flavivirus replication in vitro and is neuroprotective in a mouse model of Zika virus pathogenesis NW Hanners, KB Mar, IN Boys, JL Eitson, PC De La Cruz-Rivera, ... Proceedings of the National Academy of Sciences 118 (49), e2111266118, 2021 | 25 | 2021 |
Evolution of the interferon response: lessons from ISGs of diverse mammals MB McDougal, IN Boys, P De La Cruz-Rivera, JW Schoggins Current opinion in virology 53, 101202, 2022 | 18 | 2022 |
Structural homology screens reveal host-derived poxvirus protein families impacting inflammasome activity IN Boys, AG Johnson, MR Quinlan, PJ Kranzusch, NC Elde Cell reports 42 (8), 2023 | 7* | 2023 |
FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms MS Ahmed, AB Farag, IN Boys, P Wang, I Menendez-Montes, ... Biomedicine & Pharmacotherapy 162, 114614, 2023 | 6 | 2023 |
Identification of atovaquone and mebendazole as repurposed drugs with antiviral activity against SARS-CoV-2 MS Ahmed, AB Farag, P Wang, IN Boys, I Menendez-Montes, N Uyen Cambridge Open Engage: Cambridge, UK, 2021 | 5 | 2021 |
Functional-genomic analysis reveals intraspecies diversification of antiviral receptor transporter proteins in Xenopus laevis IN Boys, KB Mar, JW Schoggins PLoS genetics 17 (5), e1009578, 2021 | 2 | 2021 |
Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo DL Kober, MC Caballero Van Dyke, JL Eitson, IN Boys, MB McDougal, ... Mbio 15 (6), e00768-24, 2024 | 1 | 2024 |
When viruses do not go gentle into that good night IN Boys, NC Elde Cell Host & Microbe 30 (11), 1499-1500, 2022 | 1 | 2022 |
Evolution of STAT2 resistance to flavivirus NS5 occurred multiple times despite genetic constraints EC Veit, MS Salim, MJ Jung, RB Richardson, IN Boys, M Quinlan, ... Nature Communications 15 (1), 5426, 2024 | | 2024 |
IFIT1 is rapidly evolving and exhibits disparate antiviral activities across 11 mammalian orders MB McDougal, AM De Maria, E Nakahara, IN Boys, JW Schoggins bioRxiv, 2024.05. 13.593954, 2024 | | 2024 |
Identification of Receptor Transporting Proteins As Conserved Antiviral Effectors in Vertebrates IN Boys | | 2021 |
Interferon-stimulated gene LY6E enhances entry of diverse RNA viruses K Mar, I Boys, J Eitson, M McDougal, J Schoggins CYTOKINE 100, 77-78, 2017 | | 2017 |